Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02301403 · ClinicalTrials.gov registry record · Phase 4
A Comparative Effectiveness RCT of Optimized Cessation Treatments
A Phase 4 study, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- Phase 4
- Development phase
- 623
- Enrollment target
NCT02301403: Completed Phase 4 study, sponsored by University of Wisconsin, Madison.
NCT02301403 is a Phase 4 study that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 623 participants, above the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (20% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02301403, a Phase 4 study, has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 623 participants
- Enrollment target
Study Summary
This study is a 2-arm randomized clinical trial (RCT). Participants motivated to quit smoking will be randomized to one of two treatments: 1) a Modern Usual Care (M-UC) vs. 2) Abstinence-Optimized Cessation Treatment (AOCT). The components for the optimized treatment have strong theoretical and empirical support from the investigators previous screening studies.
Primary Outcome
The outcome measure consists of the number of participants reporting abstinence from smoking at 6 months that is biochemically confirmed (exhaled carbon monoxide \< 6 parts per million).
Interventions
- DRUG Nicotine patch
- BEHAVIORAL in-person counseling and quitline counseling
- DRUG Preparation Nicotine Mini-Lozenges
- DRUG Combination NRT (nicotine patch + nicotine mini-lozenges)
- BEHAVIORAL Intensive In-Person Cessation Counseling
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 623 participants |
| Start Date | 2015-01 |
| Est. Completion | 2018-02 |
| Phase | Phase 4 |
What the finished NCT02301403 record still lists
NCT02301403 is an interventional study that assigns participants to a tested intervention. The registered 623 participants enrollment target is mid-sized for trials with a published cap, above the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (20% higher).
The record links to 0 conditions, and to 5 interventions - of which Nicotine patch is the first listed.
NCT02301403 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02301403 about?
NCT02301403 is a clinical study titled "A Comparative Effectiveness RCT of Optimized Cessation Treatments". This study is a 2-arm randomized clinical trial (RCT). Participants motivated to quit smoking will be randomized to one of two treatments: 1) a Modern Usual Care (M-UC) vs. 2) Abstinence-Optimized Cessation Treatment (AOCT). The components for the optimized treatment have strong theoretical and empi...
What is the current status of trial NCT02301403?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 623 participants. The study started on 2015-01. Estimated completion is 2018-02.
What interventions are being tested in trial NCT02301403?
The interventions under investigation include: Nicotine patch (DRUG), in-person counseling and quitline counseling (BEHAVIORAL), Preparation Nicotine Mini-Lozenges (DRUG), Combination NRT (nicotine patch + nicotine mini-lozenges) (DRUG), Intensive In-Person Cessation Counseling (BEHAVIORAL).
Who is sponsoring clinical trial NCT02301403?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02301403's enrollment target sits among peer trials
623 131st of 2000 higher than 1,870 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06406049 · 624 participants · NA
Finishing HIV Project
- NCT05349227 · 625 participants · NA
Comprehensive Outcomes for After Cancer Health
- NCT06103864 · 625 participants · Phase 3
A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer
- NCT06230510 · 625 participants · NA
Milk-Tot Study: Impact of Whole Versus Low-fat Milk on Child Health
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia